Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
- PMID: 30255616
- DOI: 10.1111/joim.12831
Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
Abstract
Primary aldosteronism (PA), the most common form of secondary hypertension, can be either surgically cured or treated with targeted pharmacotherapy. PA is frequently undiagnosed and untreated, leading to aldosterone-specific cardiovascular morbidity and nephrotoxicity. Thus, clinicians should perform case detection testing for PA at least once in all patients with hypertension. Confirmatory testing is indicated in most patients with positive case detection testing results. The next step is to determine whether patients with confirmed PA have a disease that can be cured with surgery or whether it should be treated medically; this step is guided by computed tomography scan of the adrenal glands and adrenal venous sampling. With appropriate surgical expertise, laparoscopic unilateral adrenalectomy is safe, efficient and curative in patients with unilateral adrenal disease. In patients who have bilateral aldosterone hypersecretion, the optimal management is a low-sodium diet and lifelong treatment with a mineralocorticoid receptor antagonist administered at a dosage to maintain a high-normal serum potassium concentration without the aid of oral potassium supplements.
Keywords: adrenal vein sampling; aldosterone; hypertension; hypokalaemia.
© 2018 The Association for the Publication of the Journal of Internal Medicine.
Similar articles
-
[Primary aldosteronism: from diagnosis to therapy in clinical practice].G Ital Cardiol (Rome). 2021 Apr;22(4):319-326. doi: 10.1714/3574.35578. G Ital Cardiol (Rome). 2021. PMID: 33783452 Italian.
-
[Primary aldosteronism: The Mayo Clinic approach].Ter Arkh. 2020 Nov 24;92(10):83-87. doi: 10.26442/00403660.2020.10.000754. Ter Arkh. 2020. PMID: 33346484 Russian.
-
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.J Hypertens. 2003 Nov;21(11):2149-57. doi: 10.1097/00004872-200311000-00025. J Hypertens. 2003. PMID: 14597859
-
Diagnosis and management of primary aldosteronism.Arch Endocrinol Metab. 2017 May-Jun;61(3):305-312. doi: 10.1590/2359-3997000000274. Arch Endocrinol Metab. 2017. PMID: 28699986 Free PMC article. Review.
-
Primary aldosteronism: renaissance of a syndrome.Clin Endocrinol (Oxf). 2007 May;66(5):607-18. doi: 10.1111/j.1365-2265.2007.02775.x. Clin Endocrinol (Oxf). 2007. PMID: 17492946 Review.
Cited by
-
Illness perspectives in patients with primary aldosteronism.PLoS One. 2022 Nov 28;17(11):e0277902. doi: 10.1371/journal.pone.0277902. eCollection 2022. PLoS One. 2022. PMID: 36441675 Free PMC article.
-
Diagnostic Accuracy of Aldosterone and Renin Measurement by Chemiluminescence for Screening of Patients with Primary Aldosteronism.Int J Mol Sci. 2024 Aug 2;25(15):8453. doi: 10.3390/ijms25158453. Int J Mol Sci. 2024. PMID: 39126022 Free PMC article.
-
Three Discrete Patterns of Primary Aldosteronism Lateralization in Response to Cosyntropin During Adrenal Vein Sampling.J Clin Endocrinol Metab. 2019 Dec 1;104(12):5867-5876. doi: 10.1210/jc.2019-01182. J Clin Endocrinol Metab. 2019. PMID: 31408156 Free PMC article.
-
Ambulatory fludrocortisone suppression test in the diagnosis of primary aldosteronism: Safety, accuracy and cost-effectiveness.Clin Endocrinol (Oxf). 2022 Dec;97(6):730-739. doi: 10.1111/cen.14793. Epub 2022 Jul 4. Clin Endocrinol (Oxf). 2022. PMID: 35762021 Free PMC article.
-
Practical recommendations for antihypertensive therapy during the primary aldosteronism screening test.Endocrine. 2024 Jan;83(1):188-195. doi: 10.1007/s12020-023-03580-8. Epub 2023 Nov 4. Endocrine. 2024. PMID: 37924464
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical